Buy Epclusa Generic (sofosbuvir/velpatasvir) – International Cost
$295.00 USD
MyHep All™ is a licensed generic of Epclusa®. It’s a direct-acting antiviral used to treat chronic Hepatitis C (HCV) across all genotypes in patients with or without liver cirrhosis. For most patients, 12 weeks of treatment is needed to reach cure. MyHep All™ is produced in a USFDA approved factory in India.
Bottle Size : 28 Tablets (4 weeks supply)
Active Ingredients : Sofosbuvir 400 MG / Velpatasvir 100 MG
Produced by Mylan Pharmaceuticals®
Delivery of medication is fully guaranteed and takes 4 to 9 days by USPS or DHL Express
In stock
- Epclusa® overall established cure rate across all 6 strains of Hepatitis C is roughly 96%
- For treatment experienced genotype 3 patients or for patients with advanced Liver cirrhosis (decompensated), treatment duration is 24 weeks instead of 12 weeks
- Epclusa®’s side effects profile is quite mild especially with enough water intake
- Consult a doctor before concurrent administration of other drugs and supplements to avoid drug interactions
- Epclusa® is approved by the FDA and EMA for use in adults and children aged six years and older or weighing at least 37 pounds (17 kilograms)
- You can visit the FixHepC forum to post any questions you may have about Hepatitis C treatment
Please refer to the originator’s website to learn all the information needed to use this medicine safely and effectively.
Only logged in customers who have purchased this product may leave a review.
Related products
Reviews
There are no reviews yet.